0.8020
21-11月-24 08:23:05
15 分の遅延
株式
-0.0200
-2.43%
本日の幅
0.8020 - 0.8210
ISIN
FR0010557264
ソース
Cboe
AB Science announces that a new independent publication confirms the role of masitinib as a potential therapy in neurodegenerative disorders including Alzheimer's Disease
08 3 2021 02:02:16 提供 Nasdaq GlobeNewswire
AB Science announces that a new independent publication confirms the role of masitinib as a potential therapy in pancreatic cancer
23 2 2021 02:02:09 提供 Nasdaq GlobeNewswire
AB Science announces that a new independent publication confirms that masitinib has anti-vital activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating Covid-19
25 1 2021 02:26:50 提供 Nasdaq GlobeNewswire